Arkolith/Insider Trading/RUBY/Form 4

Carmona Jose

Chief Financial OfficerRubius Therapeutics, Inc. (RUBY) · full profile →Form 4 · filed Feb 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2022Grant(A)35K—$035K
Jan 31, 2022Grant(A)144K—$0144K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-22-000696) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML